BioSpace News Archive

Experic today announced the appointment of Derek Hennecke as an independent member of its board of directors.

Satsuma Pharmaceuticals, Inc. today announced positive safety, tolerability and efficacy results from its recent analysis of the Company’s ongoing STS101 ASCEND Phase 3 open-label, long-term safety trial.

Schrödinger today announced that the company will host Platform Day in New York City on Thursday, October 6, 2022, beginning at 10:00 AM ET.

Shuttle Pharmaceuticals Holdings, Inc. (Nasdaq: SHPH) entered into an agreement with TCG GreenChem, Inc. to manufacture Ropidoxuridine, the Company’s lead clinical sensitizer drug candidate, for use in formulating the drug product for testing in clinical trials of Ropidoxuridine and RT of cancers.

Genome Medical, the leading telehealth provider of genetic services and genomics-based care, and Pierian, the global leader in advanced clinical genomics technology and services, announced a collaboration designed to streamline and optimize onsite genomics programs for health care organizations and provider groups.

Veranex, the only truly comprehensive, global, tech-enabled service provider dedicated to the medical technology industry, announced today that it has acquired Medidee, a top MedTech consultancy company headquartered in Lausanne, Switzerland.